Lv21
150 积分 2025-03-09 加入
Pembrolizumab-induced myocarditis, myositis, and myasthenia gravis overlap syndrome (IM3OS) treated with Efgartigimod: case report
1小时前
已完结
Immune Checkpoint Inhibitor-Induced Myocarditis, Myositis, Myasthenia Gravis and Transaminitis: A Case Series and Review
4个月前
已完结
Checks Imbalanced: Neurologic Complications and Immune Checkpoint Inhibitors (P3-11.021)
5个月前
已关闭
Epithelial-mesenchymal transition
6个月前
已完结
皖公网安备34019202002308
